Caplin Point Laboratories rose 1.14% to Rs 1,389.60 at 11:22 IST on BSE after the company fixed 20 October 2016 as record date for 5-for-1 stock split.
The announcement was made after market hours yesterday, 5 October 2016.Meanwhile, the S&P BSE Sensex was up 94.33 points or 0.33% at 28,315.31.
On BSE, so far 775 shares were traded in the counter as against average daily volume of 3,507 shares in the past one quarter. The stock hit a high of Rs 1,405 and a low of Rs 1,384.10 so far during the day. The stock had hit a 52-week high of Rs 1,582 on 4 January 2016. The stock had hit a 52-week low of Rs 835.25 on 12 February 2016. The stock had outperformed the market over the past one month till 5 October 2016, advancing 12.21% compared with 1.09% fall in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 29.44% as against Sensex's 3.88% rise.
The small-cap company has equity capital of Rs 15.11 crore. Face value per share is Rs 10.
On a consolidated basis, Caplin Point Laboratories' net profit rose 27.58% to Rs 16.14 crore on 21.31% growth in net sales to Rs 85.08 crore in the quarter ended 30 June 2016 over the quarter ended 30 June 2015.
Caplin Point Laboratories is a pharmaceutical company, catering predominantly to emerging markets of Latin America and Africa.
Powered by Capital Market - Live News